Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Better Therapeutics, Inc. BTTX

Full chart Compare
Set alert

Price alert · BTTX

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.0001 52-week range 0.0002
YTD
0.00%
1 year
0.00%

Financial health

Altman Z-Score

-27.28 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.7×
FY 2019: -40.0×FY 2020: -9.6×FY 2021: -2.7×FY 2022: -0.7×
FY 2019 5y median -6.2× FY 2022
P/S 0.0×
FY 2019: 13111×FY 2020: 9447×FY 2021: 0.0×FY 2022: 0.0×
FY 2019 5y median 4723× FY 2022
P/B -29.1×
FY 2019: -390×FY 2020: -11.2×FY 2021: 3.0×FY 2022: -29.1×
FY 2019 5y median -20.1× FY 2022
P/FCF -0.9×
FY 2019: -26.4×FY 2020: -9.4×FY 2021: -3.4×FY 2022: -0.9×
FY 2019 5y median -6.4× FY 2022
EV/EBITDA -0.7×
FY 2019: -42.1×FY 2020: -12.6×FY 2021: -2.0×FY 2022: -0.7×
FY 2019 5y median -7.3× FY 2022
EV/Sales 0.0×
FY 2019: 13347×FY 2020: 9512×FY 2021: 0.0×FY 2022: 0.0×
FY 2019 5y median 4756× FY 2022
FCF Yield -115.2%
FY 2019: -3.8%FY 2020: -10.7%FY 2021: -29.1%FY 2022: -115.2%
FY 2019 5y median -19.9% FY 2022

Profitability

Gross Margin 0.0%
FY 2019: -4888.9%FY 2020: -8425.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2019 5y median -2444.4% FY 2022
Operating Margin 0.0%
FY 2019: -32072.2%FY 2020: -79037.5%FY 2021: 0.0%FY 2022: 0.0%
FY 2019 5y median -16036.1% FY 2022
Net Margin 0.0%
FY 2019: -32194.4%FY 2020: -79837.5%FY 2021: 0.0%FY 2022: 0.0%
FY 2019 5y median -16097.2% FY 2022
ROE 4422.7%
FY 2019: 957.9%FY 2020: 94.5%FY 2021: -109.8%FY 2022: 4422.7%
FY 2019 5y median 526.2% FY 2022
ROIC -273.7%
FY 2019: -131.4%FY 2020: -109.5%FY 2021: -65.9%FY 2022: -273.7%
FY 2019 5y median -120.4% FY 2022
ROA -173.3%
FY 2019: -118.7%FY 2020: -100.0%FY 2021: -79.2%FY 2022: -173.3%
FY 2019 5y median -109.4% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: -55.6%FY 2021: -100.0%FY 2022: 0.0%
FY 2019 FY 2022
Operating Income -25.2%
FY 2019: 0.0%FY 2020: -9.5%FY 2021: -383.3%FY 2022: -25.2%
FY 2019 FY 2022
EPS (diluted) 1.2%
FY 2019: 0.0%FY 2020: -316.0%FY 2021: -64.4%FY 2022: 1.2%
FY 2019 FY 2022
Free Cash Flow 5.6%
FY 2019: 0.0%FY 2020: 9.8%FY 2021: -294.7%FY 2022: 5.6%
FY 2019 FY 2022

Financial Health

Current Ratio 1.4×
FY 2019: 2.0×FY 2020: 0.8×FY 2021: 9.6×FY 2022: 1.4×
FY 2019 5y median 1.7× FY 2022
Quick Ratio 1.4×
FY 2019: 2.0×FY 2020: 0.8×FY 2021: 9.6×FY 2022: 1.4×
FY 2019 5y median 1.7× FY 2022
Debt / Equity -16.6×
FY 2019: -8.3×FY 2020: -0.1×FY 2021: 0.3×FY 2022: -16.6×
FY 2019 5y median -4.2× FY 2022
Net Debt / EBITDA 0.0×
FY 2019: -0.7×FY 2020: -0.1×FY 2021: 0.8×FY 2022: 0.0×
FY 2019 5y median -0.0× FY 2022
Interest Coverage -25.7×
FY 2019: -525×FY 2020: -63.2×FY 2021: -165×FY 2022: -25.7×
FY 2019 5y median -114× FY 2022

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2019 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2019 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31